IP Library Granted Patent US 7,112,413
Granted Patent B2
US 7,112,413 · App. 10/679,368 · Granted Sep 26, 2006

Heteroaryl substituted benzothiazole dioxetanes

Assignee: Applera Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,112,413
App. No.
10/679,368
Granted
Sep 26, 2006
Kind
B2
Abstract

Chemiluminescent heteroaryl substituted benzothiazole 1,2-dioxetane compounds capable of producing light energy when decomposed are provided. These chemiluminescent compounds are represented by the general formula: The heteroaryl substituent Y can be, for example, a pyridyl group or a benzothiazolyl group. The heteroaryl substituted benzothiazole compounds are substantially stable at room temperature. Kits including the heteroaryl substituted dioxetane compounds as well as methods for using these compounds for detecting the presence of one or more analytes in a sample are also provided.

Claims (42)

1. A chemiluminescent compound of the general formula (II):

wherein Y is a heteroaryl group, X is a protecting group which can be removed by chemical or enzymatic means, and R 2 -R 6 are independently hydrogen, alkyl, substituted alkyl, aryl, or substituted aryl and wherein R 3 and R 4 may be joined as a spiro-fused cycloalkyl group.

2. The compound of claim 1 , wherein X is a phosphate group.

3. The compound of claim 1 , wherein the heteroaryl group Y is selected from the group consisting of pyridyl, benzothiozolyl, benzoxazolyl, benzofuranyl, benzothienyl, thiazolyl, isoxazolyl, isothiazolyl, quinolinyl, and pyrimidinyl.

4. The compound of claim 3 , wherein the heteroaryl group Y is a pyridyl selected from the group consisting of 2-pyridyl, 3-pyridyl, and 4-pyridyl.

5. The compound of claim 3 , wherein the heteroaryl group Y is 2-benzothiazolyl.

6. The compound of claim 3 , wherein the heteroaryl group Y is a thiazolyl selected from the group consisting of 2-thiazolyl, 4-thiazolyl, and 5-thiazolyl.

7. The compound of claim 3 , wherein the heteroaryl group Y is an isoxazolyl selected from the group consisting of 3-isoxazolyl, 4-isoxazolyl, and 5-isoxazolyl.

8. The compound of claim 3 , wherein the heteroaryl group Y is an isothiazolyl selected from the group consisting of 3-isothiazolyl, 4-isothiazolyl, and 5-isothiazolyl.

9. The compound of claim 1 , wherein the heteroaryl group is substituted with one or more electron active groups.

10. A kit for detecting the presence of an analyte in a sample comprising:

the 1,2-dioxetane compound of claim 1 ; and

an enzyme or enzyme conjugate which, in the presence of the dioxetane, causes the dioxetane to decompose and generate chemiluminescent emissions.

11. The kit of claim 10 , wherein the substance comprises an enzyme.

12. The kit of claim 10 , further comprising a chemiluminescent enhancing agent which enhances the chemiluminescent emissions generated by the decomposition of the dioxetane.

13. The kit of claim 12 , wherein the chemiluminescent enhancing agent is a quaternary onium polymer.

14. The kit of claim 12 , further comprising an enhancement additive which further enhances the chemiluminescent emissions generated by the decomposition of the dioxetane.

15. A kit for detecting the presence of an analyte in a sample comprising:

the 1,2-dioxetane compound of claim 2 ; and

an enzyme or enzyme conjugate which, in the presence of said dioxetane, causes said dioxetane to decompose and generate chemiluminescent emissions.

16. A method for detecting the presence and/or amount of an analyte in a sample, comprising:

adding the dioxetane compound of claim 1 to the sample, wherein the analyte is an enzyme or is conjugated to an enzyme and wherein the enzyme causes the dioxetane compound to decompose and generate light;

incubating the sample; and

inspecting the sample for the presence of light;

wherein the presence of light indicates the presence of the analyte in the sample and wherein the amount of light indicates the amount of the analyte in the sample.

17. The method of claim 16 , further comprising adding a chemiluminescent enhancement agent to the sample to enhance the light generated.

18. The method of claim 17 , wherein the enhancement agent is a quatemary onium polymer.

19. The method of claim 17 , further comprising adding an enhancement additive to the sample to further enhance the light generated.

20. The method of claim 16 , wherein the step of inspecting the sample comprises detecting light with a CCD camera.

21. The method of claim 16 , wherein the analyte comprises an enzyme.

22. The method of claim 21 , wherein the enzyme is complexed with a biological moiety.

23. A method for detecting the presence and/or amount of two or more analytes in a sample, comprising:

adding at least two different chemiluminescent compounds to the sample, at least one of which is the dioxetane compound of claim 1 , wherein each of the chemiluminescent compounds are configured to emit, upon decomposition, light of different wavelengths, and wherein each of the analytes is an enzyme or is conjugated to an enzyme and wherein each enzyme causes the corresponding chemiluminescent compound to decompose and generate light of a particular wavelength;

incubating the sample; and

inspecting the sample for the presence of light;

wherein the presence of light emitted by one of the chemiluminescent compounds indicates the presence of the corresponding analyte in the sample and wherein the amount of light emitted by one of the chemiluminescent compounds indicates the amount of the corresponding analyte in the sample.

24. The method of claim 23 , wherein at least one of the chemiluminescent compounds added to the sample is the dioxetane compound of claim 1 wherein the substituent Y is 3-pyridyl.

25. The method of claim 24 , wherein a second chemiluminescent compound added to the sample emits light in the blue portion of the visible spectrum.

26. The method of claim 25 , wherein the second chemiluminescent compound emits light having a λ max of approximately 470 nm.

27. The compound of claim 3 , wherein the heteroaryl group Y is 2-benzoxazolyl.

28. The compound of claim 3 , wherein the heteroaryl group Y is 2-benzofuranyl.

29. The compound of claim 3 , wherein the heteroaryl group Y is 2-benzothienyl.

Assignments (5)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2004
From: PE CORPORATION (NY)
To: APPLERA CORPORATION
Reel/Frame 015394/0368 →
Continuity (4)
Continuation 0994565200 · Sep 5, 2001
Continuation In Part 0936204700 · Jul 28, 1999
Provisional Application 6009433600 · Jul 28, 1998
Related Publication 20040072252A1 · Apr 15, 2004